Furthermore, at the global transcript level, both PDCD1-mutant and post-hyperprogression T-NHL samples showed a significant enrichment in c-FOS, FOSL1, FOSL2, c-JUN and BATF target genes (Fig. 7h). The gene discussed is BATF; the disease is non-Hodgkin lymphoma.